Magali Taiel
Hoofd Techniek/Wetenschap/O&O bij GENSIGHT BIOLOGICS S.A.
Oorsprong van het eerstegraads netwerk van Magali Taiel
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 25 | |
| Public Company | Pharmaceuticals: Major | 6 | |
Universite Paris Cite
1
| College/University | Other Consumer Services | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Magali Taiel via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| X4 PHARMACEUTICALS, INC. | Biotechnology | Chairman Founder Director/Board Member | |
| Janssen Biotherapeutics | Corporate Officer/Principal Corporate Officer/Principal | ||
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| University of Cambridge | College/University | Corporate Officer/Principal Undergraduate Degree | |
Abingworth LLP
 Abingworth LLP Investment ManagersFinance Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022. | Investment Managers | Consultant / Advisor Private Equity Investor | |
Adaptate Biotherapeutics Ltd.
 Adaptate Biotherapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Adaptate Biotherapeutics Ltd. engages in research and experimental development on biotechnology. The company was founded on August 21, 2019 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Chairman Chief Executive Officer | |
Gammadelta Therapeutics Ltd.
 Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Gammadelta Therapeutics Ltd. is developing the potential of gamma delta (?d) cells to create improved immunotherapy of cancer and other serious diseases. The company was founded by Raj Mehta in 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
| Albert Einstein College of Medicine, Inc. | College/University | Corporate Officer/Principal Doctorate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Utrecht | College/University | Graduate Degree Undergraduate Degree | |
| AURA BIOSCIENCES, INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
| MORPHOSYS AG | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| ABLYNX | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| The University of Texas at Austin | College/University | Doctorate Degree Doctorate Degree | |
| PIXIUM VISION | Medical Specialties | Founder Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO Chief Executive Officer | |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
Bamboo Therapeutics, Inc.
 Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | Biotechnology | General Counsel | |
Cornovum SASU
 Cornovum SASU Financial ConglomeratesFinance Cornovum SASU is an investment holding French company. The company is based in Paris, France. The company was founded in 2015. The CEO is Maïlys Ferrère. | Financial Conglomerates | Chief Executive Officer | |
| University of Pennsylvania | College/University | Doctorate Degree | |
| Bpifrance Participations SA | Financial Conglomerates | Chief Investment Officer | |
Groupe Grimaud La Corbière SA
 Groupe Grimaud La Corbière SA BiotechnologyHealth Technology Groupe Grimaud La Corbière SA specializes in biopharmaceutical and animal genetic solutions. It operates under two segments: Genetic Selection and sale of animal breeders such as broiler, and layer chickens, pigs, ducks, guinea, fowl, rabbits and pigeons; while Biopharmacy serves human and animal health such as vaccines, pharmaceutical proteins and serums for specific pathogen. The company was founded in 1966 and is headquartered in Roussay, France. | Biotechnology | Director/Board Member | |
Fonds Stratégique d'Investissement Fund
 Fonds Stratégique d'Investissement Fund Investment ManagersFinance Fonds Stratégique d'Investissement was created by the French Government in 2008 and integrated BPIFrance on 2013. This fund invests in small and middle sized French companies. | Investment Managers | Chief Investment Officer | |
| Standards Coordinating Body | Director/Board Member | ||
Novasep Holding SAS
 Novasep Holding SAS Chemicals: Major DiversifiedProcess Industries Novasep Holding SAS provides manufacturing solutions for the life science industries. Its products include agrochemicals fine chemicals and food ingredients. The company was founded by Roger-Marc Nicoud in 1995 and is headquartered in Lyon, France. | Chemicals: Major Diversified | Director/Board Member | |
StrideBio, Inc.
 StrideBio, Inc. BiotechnologyHealth Technology Stridebio, Inc. focuses on creating and developing novel adeno-associated viral vector technologies. The company was founded by Aravind Asokan, Mavis Agbandje-McKenna and Patrick Ritschel and is headquartered in Durham, NC. | Biotechnology | Corporate Officer/Principal | |
| VALNEVA | Biotechnology | Director/Board Member | |
Devialet SA
 Devialet SA Electronics/AppliancesConsumer Durables Devialet SA manufactures audio integrated amplifiers. Its products include Devialet 120, Devialet 400, Devialet 200, and Devialet 800. The firm also offers home audio amplification system called Devialet ensemble, D-Premier, and Devialet 250. The company was founded by Pierre-Emmanuel Calmel, Mathias Moronvalle, Emmanuel Nardin, and Quentin Sannié in 2007 and is headquartered in Paris, France. | Electronics/Appliances | Director/Board Member | |
Doctolib SAS
 Doctolib SAS Packaged SoftwareTechnology Services Doctolib SAS develops software for the health industry. This software improves the efficiency of hospitals and reinforces the cooperation with colleagues. The company was founded by Ivan Schneider, Jessy Bernal, and Stanislas Niox-Chateau on August 5, 2013 and is headquartered in Levallois-Perret, France. | Packaged Software | Director/Board Member | |
| REGENXBIO INC. | Pharmaceuticals: Major | General Counsel | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BAVARIAN NORDIC A/S | Pharmaceuticals: Major | General Counsel | |
Biologics Consulting Group, Inc.
 Biologics Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Biologics Consulting Group, Inc. provides regulatory and product development advisory services for drugs and device products. It specializes in the preparation and review of CBER, CDER and CDRH regulatory applications, facility inspection, process validation packages, and electronic submissions. The company was founded by James G. Kenimer in 1993 and is headquartered in Alexandria, VA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The University of Chicago | College/University | Doctorate Degree | |
| Wayne State University (Michigan) | College/University | Undergraduate Degree | |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | Corporate Officer/Principal | |
American Society of Gene & Cell Therapy
 American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Miscellaneous Commercial Services | Director/Board Member | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member | |
| Advanced Therapies Partners LLC | President | ||
| SEQUANS COMMUNICATIONS S.A. | Semiconductors | Director/Board Member | |
| ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member | |
| BIOTIE THERAPIES CORP | Pharmaceuticals: Major | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 23 |
| Frankrijk | 18 |
| Verenigd Koninkrijk | 5 |
| België | 3 |
| Nederland | 3 |
Sectoraal
| Health Technology | 25 |
| Consumer Services | 9 |
| Finance | 7 |
| Commercial Services | 5 |
| Process Industries | 2 |
Operationeel
| Director/Board Member | 134 |
| Corporate Officer/Principal | 63 |
| Chairman | 33 |
| Independent Dir/Board Member | 31 |
| Chief Tech/Sci/R&D Officer | 29 |
Sterkste connecties
| Insiders | |
|---|---|
| Henri A. Termeer | 42 |
| Bernard Gilly | 32 |
| Michael Wyzga | 31 |
| Barrett Katz | 23 |
| Guido Magni | 23 |
| Maïlys Ferrère | 21 |
| Jeff Clavier | 17 |
| Cédric Moreau | 14 |
| Elsy Boglioli Hofman | 14 |
| Maritza McIntyre | 14 |
| Peter Goodfellow | 13 |
| Natalie Mount | 10 |
| Noreen Henig | 10 |
| David Rodman | 10 |
| Robert Friesen | 9 |
- Beurs
- Insiders
- Magali Taiel
- Bedrijfsconnecties
